ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 17, 2026 07:11 UTC
-
One-shot hair fix? new study pits nanofat against daily cream
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat tissue) can outperform either platelet-rich plasma (PRP) injections or daily topical minoxidil 5% for treating male and female pattern baldness. Sixty adults aged 18-50 with confirmed androgenetic alopecia will…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New hair loss pill enters final testing phase
Symptom relief Not yet recruitingThis study tests an oral medication called N1087 (minoxidil) to see if it can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo pill daily for 24 weeks. The main goal is to measure change…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 16, 2026 12:49 UTC
-
Scientists map hair loss at the cellular level to unlock new treatments
Knowledge-focused Not yet recruitingThis study aims to understand why hair follicles stop working in male pattern baldness. Researchers will collect scalp samples from 12 men (younger and older) with and without hair loss. Using advanced technology, they will map cells and genes to find key targets for future treat…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC